FDA’S REGULATORY POLICIES IMPACTING THE RISE OF AI IN INTELLIGENT MEDICAL PRODUCT DEVELOPMENT AND OPERATIONS

AI, machine learning (ML), and other digital health technologies have the potential to transform healthcare by accelerating the development of new medical products, including both pharmaceuticals and medical devices; optimize medical product operations; and revolutionize healthcare delivery.

As these advanced technologies become more prevalent in the medical space, the US Food and Drug Administration (FDA) has been updating its regulatory policies to keep pace. This webinar will discuss the FDA’s policies on the use of AI/ML for pharmaceutical and medical device development and operations, how the FDA regulates AI/ML intended for health-related uses, and recent FDA developments related to AI/ML.